Maxcyte (MXCT) Debt Ratio (2020)
Maxcyte (MXCT) posted quarterly Debt Ratio of 0.09 for Q4 2020.
Maxcyte (MXCT) Debt Ratio (2020) Analysis & Trends
Maxcyte (MXCT) has reported Debt Ratio for 1 consecutive years, with 0.09 the latest figure, recorded in Q4 2020.
- In Q4 2020, Debt Ratio changed N/A year-over-year to 0.09; the TTM figure through Dec 2020 stood at 0.09 (changed N/A YoY), while the FY2020 annual figure was 0.09, changed N/A from the prior year.
- Debt Ratio was little changed at 0.09 in Q4 2020 per MXCT's latest filing.
- Across five years, Debt Ratio topped out at 0.09 in Q4 2020 and bottomed at 0.09 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.20 Bn | 193.60 Bn | 7.27 Bn | 0.30 |
| 2 | Stryker | 127.66 Bn | 124.19 Bn | 4.50 Bn | 0.31 |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 0.30 |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 0.28 |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 0.04 |
| 6 | Dexcom | 34.37 Bn | 32.42 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.89 Bn | 31.78 Bn | 2.18 Bn | 0.27 |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 0.28 |
| 9 | Steris | 23.03 Bn | 22.55 Bn | 684.20 Mn | 0.18 |
| 10 | Maxcyte | 148.48 Mn | 148.48 Mn | 5.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 0.09 |